Tadashi Ohara
Overview
Explore the profile of Tadashi Ohara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
542
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ohara T, Mori T
Anticancer Res
. 2019 Sep;
39(9):4659-4666.
PMID: 31519564
Background/aim: Short-chain fatty acids (SCFAs) inhibit human colorectal cancer cell growth and tumorigenicity. We investigated the mechanism of the anti-proliferative effects of SCFAs on human colorectal cancer cells by examining...
2.
Ohara T
PLoS One
. 2019 Mar;
14(3):e0214085.
PMID: 30889205
Background: Fecal microbiota transplantation (FMT) is an effective therapeutic approach for the treatment of functional gastrointestinal disease by restoring gut microbiota; however, there is a lack of sufficient understanding regarding...
3.
Ohara T, Suzutani T
Clin Case Rep
. 2018 Nov;
6(11):2029-2032.
PMID: 30455884
We have presented the first case report of FMT therapy for a patient with chronic intractable constipation. This therapy resulted in good, medium-term outcomes. Follow-up analysis of the intestinal flora...
4.
Ohara T, Suzutani T
Euroasian J Hepatogastroenterol
. 2018 Jul;
8(1):11-17.
PMID: 29963455
Introduction: We aimed to investigate the effects of intake of yogurt containing (BB536-y) and fructo-oligosaccharides (FOS) in preventing colorectal carcinogenesis in healthy subjects, and the preventive effects of short-chain fatty...
5.
Iwamoto J, Mizokami Y, Shimokobe K, Yara S, Murakami M, Kido K, et al.
Hepatogastroenterology
. 2011 Jun;
58(106):301-5.
PMID: 21661386
Background/aims: Capsule endoscopy (CE) represents a significant advance in the investigation of small bowel diseases. Little is known about the clinical outcome of patients with obscure gastrointestinal bleeding (OGIB). Methodology:...
6.
Ohara T, Oteki T, Suzuki T, Suzuki M, Matsuzaki Y
Hepatogastroenterology
. 2011 Apr;
58(105):133-6.
PMID: 21510300
Background/aims: Therapeutic results for patients with hepatitis C and B complex or patients with genotype lb high viral load treatment-resistant hepatitis C are still not sufficient. The therapeutic effects of...
7.
Ohara T, Kanoh Y, Tani N, Ohdaira H, Suzuki Y, Kameyama J, et al.
Mol Med Rep
. 2011 Apr;
2(1):17-21.
PMID: 21475784
To date, no enclosure method for risk grouping patients with poorly-differentiated gastric adenocarcinoma has been identified. We examined the relationship between mutations in toll-like receptor 4 (TLR4) and patients with...
8.
Ohara T, Yoshino K, Kitajima M
Hepatogastroenterology
. 2011 Mar;
57(104):1411-5.
PMID: 21443095
Background/aims: There have been no reports on the relationship between the analyses of the intestinal flora of colorectal cancer patients and colorectal carcinogenesis. In this study we investigated the differences...
9.
Kanoh Y, Ohara T, Akahoshi T
Clin Lab
. 2011 Mar;
57(1-2):37-46.
PMID: 21391463
Background: The blood-cerebrospinal fluid barrier (BCB) has selectivity for protein components with different molecular weights. Protein components in the cerebrospinal fluid (CSF) change when the BCB is damaged. We calculated...
10.
Ohdaira H, Suzuki Y, Tsutsui M, Iwasaki T, Arita M, Noro T, et al.
Surg Laparosc Endosc Percutan Tech
. 2010 Dec;
20(6):e206-10.
PMID: 21150404
A 29-year-old man with a type 4 tumor, in the lower third of the stomach, and carcinomatous ascites was diagnosed by aspiration cytology of the ascitic fluid. Curative resection was...